Clinical trial
The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™…
NCT00235131 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00235131 |
|---|---|
| Title | The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ Stent |
| Official title | A Clinical Investigation of the Cordis S.M.A.R.T. ™ CONTROL ™ Nitinol Stent System Versus the Bard® Luminexx™ 6F Vascular Stent for the Treatment of TASC C & D Superficial Femoral Artery Long Lesions |
| Acronym | SUPER SL |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Arterial Occlusive Diseases |
| Intervention type | Device |
| Interventions | Smart Stent, Luminexx Stent |
| Enrollment | 200 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | May 1, 2009 |
| First posted | Oct 10, 2005 |
| Last update posted | Feb 4, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: